F m Investments LLC Acquires 10,101 Shares of HCA Healthcare, Inc. $HCA

Key Points

• F m Investments LLC boosted its stake in HCA Healthcare by 94.8% in Q3, buying an additional 10,101 shares to hold 20,758 shares worth about $8.85 million.
• HCA beat expectations with Q EPS $8.01 and revenue of $19.51 billion (up 6.7% YoY), issued FY2026 guidance of 29.10–31.50 EPS, and carries a consensus rating of Moderate Buy with a $537.73 price target.
• The company raised its quarterly dividend to $0.78 (annualized $3.12, ~0.6% yield), while insiders have been net sellers (15,214 shares sold in the past 90 days), leaving insiders with 1.30% ownership.

F m Investments LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 94.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,758 shares of the company's stock after buying an additional 10,101 shares during the period. F m Investments LLC's holdings in HCA Healthcare were worth $8,847,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in the stock. Capital World Investors boosted its position in HCA Healthcare by 3.8% during the third quarter. Capital World Investors now owns 4,959,336 shares of the company's stock valued at $2,113,662,000 after purchasing an additional 179,443 shares in the last quarter. Norges Bank bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $1,152,408,000. Arrowstreet Capital Limited Partnership raised its stake in shares of HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company's stock worth $880,199,000 after acquiring an additional 36,414 shares in the last quarter. Viking Global Investors LP boosted its stake in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Finally, Legal & General Group Plc increased its position in shares of HCA Healthcare by 0.8% during the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company's stock worth $479,267,000 after purchasing an additional 8,478 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on HCA shares. JPMorgan Chase & Co. boosted their target price on HCA Healthcare from $420.00 to $535.00 and gave the stock a "neutral" rating in a research note on Friday, February 20th. Weiss Ratings restated a "buy (b)" rating on shares of HCA Healthcare in a research note on Monday, December 29th. Zacks Research cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 27th. Wall Street Zen lowered shares of HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, February 14th. Finally, Mizuho boosted their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an "outperform" rating in a report on Wednesday, February 25th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $537.73.

HCA Healthcare Trading Up 0.2%

HCA opened at $533.39 on Friday. The firm has a 50 day moving average of $507.05 and a two-hundred day moving average of $469.55. The firm has a market capitalization of $119.28 billion, a PE ratio of 18.79, a P/E/G ratio of 1.63 and a beta of 1.34. HCA Healthcare, Inc. has a 12-month low of $313.21 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts' consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the prior year, the business earned $6.22 earnings per share. The business's quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.99%.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares of the company's stock, valued at approximately $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares of the company's stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 in the last ninety days. Insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.